Certara, Inc. (CERT)
收市後：
- Zacks
Puma Biotechnology (PBYI) Soars 14.0%: Is Further Upside Left in the Stock?
Puma Biotechnology (PBYI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- Insider Monkey
Certara, Inc. (NASDAQ:CERT) Q4 2023 Earnings Call Transcript
Certara, Inc. (NASDAQ:CERT) Q4 2023 Earnings Call Transcript February 29, 2024 Certara, Inc. misses on earnings expectations. Reported EPS is $0.09 EPS, expectations were $0.11. CERT isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello and thank you for standing […]
- Zacks
Certara, Inc. (CERT) Lags Q4 Earnings Estimates
Certara, Inc. (CERT) delivered earnings and revenue surprises of -18.18% and 1.40%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
